ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,198Hybrid

Tissue Engineering Part A

Acronym:ten
•
Abbreviation (ISO):Tissue Eng. Part A
•
Identifier (ISSN):1937-3341(Print)/1937-335X(Online)
•
Publisher:Mary Ann Liebert Inc.
Former Names:
TISSUE ENG PT A
Clarivate JCR Index Advisory: Name Changed (Active in JCR)
Clarivate IF (2026)
2.8↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Tissue Engineering Part A

WoS Q3
0246020183.6220193.520203.8520214.0820224.120233.520242.920252.82026
Annual Impact Factor Metric
Current (2026):2.8
Scopus SJR & RankScopus Q2
0.704
#8,198

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
142

142 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate2.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
70articles/year
7.41% Gold OA•92.98% Original Research

Aims & Scope

Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.

Topics Covered (Recognized by AI)
Medicine94.2%Biology93.9%Genetics90%Chemistry88.1%Biochemistry78.3%Cell biology73.8%Engineering65%Biomedical engineering61.4%Internal medicine58.4%Pathology57%In vitro46.9%Tissue engineering41.2%Materials science40.8%Anatomy40.8%Stem cell36.1%Organic chemistry35.1%Cell32.2%Mesenchymal stem cell31.7%Immunology29.9%Physics29.9%Computer science29.6%Endocrinology28.9%Surgery28.1%Gene27.7%Composite material25.5%Extracellular matrix23.9%Programming language20.8%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL & TISSUE ENGINEERING

Q3
Rank23/32
IndexSCIE
JCRSCIE2026

CELL BIOLOGY

Q3
Rank143/207
IndexSCIE
JCRSCIE2026

ENGINEERING, BIOMEDICAL

Q3
Rank75/130
IndexSCIE
JCRSCIE2026

MATERIALS SCIENCE, BIOMATERIALS

Q4
Rank44/58
IndexSCIE
JCISCIE2026

CELL & TISSUE ENGINEERING

Q3
Rank20/32
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q3
Rank133/207
IndexSCIE
JCISCIE2026

ENGINEERING, BIOMEDICAL

Q3
Rank78/130
IndexSCIE
JCISCIE2026

MATERIALS SCIENCE, BIOMATERIALS

Q3
Rank40/58
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.8
Articles / Year12
Total Citations5
2025
IF2.9
Articles / Year86
Total Citations99
2024
IF3.5
Articles / Year90
Total Citations372
2023
IF4.1
Articles / Year91
Total Citations690
2022
IF4.08
Articles / Year64
Total Citations766

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,198Scopus Q2SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemical EngineeringEngineeringMaterials Science
Scopus Citation Rank (SJR)Q2
0.704

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.30

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,150 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations705
3-Year Documents213
Citable Documents207

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ2
BioengineeringQ2
BiomaterialsQ2
Biomedical EngineeringQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Tissue Engineering Part A (acronym: ten, abbr: Tissue Eng. Part A, ISSN: 1937-3341) is a peer-reviewed international scholarly journal in the field of Chemical Engineering, published by Mary Ann Liebert Inc. in United States. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.704 (Q2), an H-index of 142.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 70 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,150 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Mary Ann Liebert Inc.
Publication Language
English
Frequency
Monthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e523d2df-fd57-4a01-9857-60ffdf1fc791
Database Updated: 2026-09-29